Novartis Investigative Site

Renton, Washington 98057

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Cardiovascular Disease, Obesity, Overweight, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults — Completed
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early